An association between infectious diseases and macrophage activation syndrome (MAS) has been reported, yet the exact role of infection in MAS development is still unclear. Here, a retrospective analysis of the clinical records of patients with rheumatic diseases complicated with MAS who were treated in a pediatric tertiary care center between 2011 and 2020 was performed. Any infection documented within the 30 days preceding the onset of MAS was reported. Out of 125 children in follow-up for systemic rheumatic diseases, 12 developed MAS, with a total of 14 episodes. One patient experienced three episodes of MAS. Clinical and/or laboratory evidence of infection preceded the onset of MAS in 12 events. Clinical features, therapeutic strategies, and patient outcomes were described. The aim of this study was to evaluate the possible role of infection as a relevant trigger for MAS development in children with rheumatic conditions. The pathogenetic pathways involved in the cross-talk between uncontrolled inflammatory activity and the immune response to infection deserve further investigation.

Infection-triggered hyperinflammatory syndromes in children / M. Rossano, G. Rogani, M.M. D'Errico, M. Cucchetti, F. Baldo, S. Torreggiani, G. Beretta, S. Lanni, A. Petaccia, C. Agostoni, G. Filocamo, F. Minoia. - In: CHILDREN. - ISSN 2227-9067. - 9:4(2022 Apr 15), pp. 564.1-564.7. [10.3390/children9040564]

Infection-triggered hyperinflammatory syndromes in children

M. Cucchetti;G. Beretta;C. Agostoni;G. Filocamo
Penultimo
;
2022

Abstract

An association between infectious diseases and macrophage activation syndrome (MAS) has been reported, yet the exact role of infection in MAS development is still unclear. Here, a retrospective analysis of the clinical records of patients with rheumatic diseases complicated with MAS who were treated in a pediatric tertiary care center between 2011 and 2020 was performed. Any infection documented within the 30 days preceding the onset of MAS was reported. Out of 125 children in follow-up for systemic rheumatic diseases, 12 developed MAS, with a total of 14 episodes. One patient experienced three episodes of MAS. Clinical and/or laboratory evidence of infection preceded the onset of MAS in 12 events. Clinical features, therapeutic strategies, and patient outcomes were described. The aim of this study was to evaluate the possible role of infection as a relevant trigger for MAS development in children with rheumatic conditions. The pathogenetic pathways involved in the cross-talk between uncontrolled inflammatory activity and the immune response to infection deserve further investigation.
macrophage activation syndrome; infections; trigger; rheumatic diseases
Settore MED/38 - Pediatria Generale e Specialistica
15-apr-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
children-09-00564.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 225.95 kB
Formato Adobe PDF
225.95 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1060148
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact